David Spanswick

4.5k total citations · 1 hit paper
76 papers, 3.6k citations indexed

About

David Spanswick is a scholar working on Physiology, Cellular and Molecular Neuroscience and Endocrine and Autonomic Systems. According to data from OpenAlex, David Spanswick has authored 76 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Physiology, 32 papers in Cellular and Molecular Neuroscience and 29 papers in Endocrine and Autonomic Systems. Recurrent topics in David Spanswick's work include Regulation of Appetite and Obesity (24 papers), Neuroscience and Neuropharmacology Research (22 papers) and Ion channel regulation and function (15 papers). David Spanswick is often cited by papers focused on Regulation of Appetite and Obesity (24 papers), Neuroscience and Neuropharmacology Research (22 papers) and Ion channel regulation and function (15 papers). David Spanswick collaborates with scholars based in United Kingdom, Australia and United States. David Spanswick's co-authors include S.D. Logan, Michael L.J. Ashford, Mark A. Smith, M. van den Top, V E Groppi, Andrew Whyment, Kevin Lee, Vanessa H. Routh, Andrew M. Blanks and Anthony E. Pickering and has published in prestigious journals such as Nature, Cell and Nature Neuroscience.

In The Last Decade

David Spanswick

74 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Leptin inhibits hypothalamic neurons by activation of ATP-sensitive potassium channels

1997 518 citations David Spanswick, Michael L.J. Ashford et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Spanswick United Kingdom	29	2.0k	1.3k	857	813	807	76	3.6k
Qingchun Tong United States	38	2.1k 1.1×	1.5k 1.2×	803 0.9×	796 1.0×	935 1.2×	101	4.5k
Dianne P. Figlewicz United States	37	2.6k 1.3×	1.7k 1.3×	1.2k 1.4×	1.3k 1.6×	851 1.1×	65	4.9k
Ewan C. McNay United States	33	1.3k 0.6×	1.6k 1.2×	1.0k 1.2×	663 0.8×	1.1k 1.4×	55	4.5k
Young‐Hwan Jo United States	30	1.9k 1.0×	1.1k 0.8×	707 0.8×	792 1.0×	758 0.9×	63	3.5k
Xin‐Yun Lu United States	36	1.8k 0.9×	1.2k 0.9×	1.1k 1.3×	883 1.1×	913 1.1×	72	4.6k
Gareth Williams United Kingdom	37	2.3k 1.1×	939 0.7×	1.1k 1.3×	810 1.0×	496 0.6×	84	3.6k
Bin Xu China	25	1.6k 0.8×	873 0.7×	605 0.7×	713 0.9×	362 0.4×	114	3.1k
Jenni Harvey United Kingdom	39	2.1k 1.1×	1.4k 1.1×	1.4k 1.7×	1.4k 1.7×	1.1k 1.4×	75	4.6k
Csaba Fekete Hungary	48	3.2k 1.6×	1.6k 1.3×	1.2k 1.4×	1.2k 1.5×	981 1.2×	139	6.7k
David Sunter United Kingdom	23	1.9k 0.9×	827 0.6×	684 0.8×	841 1.0×	426 0.5×	28	3.1k

Countries citing papers authored by David Spanswick

Since Specialization

Citations

This map shows the geographic impact of David Spanswick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Spanswick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Spanswick more than expected).

Fields of papers citing papers by David Spanswick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Spanswick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Spanswick. The network helps show where David Spanswick may publish in the future.

Co-authorship network of co-authors of David Spanswick

This figure shows the co-authorship network connecting the top 25 collaborators of David Spanswick. A scholar is included among the top collaborators of David Spanswick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Spanswick. David Spanswick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Simonds, Stephanie E., Jack T. Pryor, Brian Lam, et al.. (2025). The metabolic and cardiovascular effects of amphetamine are partially mediated by the central melanocortin system. Cell Reports Medicine. 6(2). 101936–101936.

Reichenbach, Alex, Rachel Clarke, Romana Stark, et al.. (2022). Metabolic sensing in AgRP neurons integrates homeostatic state with dopamine signalling in the striatum. eLife. 11. 36 indexed citations

Kékesi, Orsolya, et al.. (2021). Neuron-specific responses to acetylcholine within the spinal dorsal horn circuits of rodent and primate. Neuropharmacology. 198. 108755–108755. 1 indexed citations

Dodd, Garron T., Natalie J. Michael, Robert S. Lee, et al.. (2018). Insulin regulates POMC neuronal plasticity to control glucose metabolism. eLife. 7. 89 indexed citations

Michael, Natalie J., Stephanie E. Simonds, M. van den Top, Michael A. Cowley, & David Spanswick. (2017). Mitochondrial uncoupling in the melanocortin system differentially regulates NPY and POMC neurons to promote weight-loss. Molecular Metabolism. 6(10). 1103–1112. 16 indexed citations

Rammes, Gerhard, Andreas Gravius, Maarten Ruitenberg, et al.. (2015). MRZ-99030 – A novel modulator of Aβ aggregation: II – Reversal of Aβ oligomer-induced deficits in long-term potentiation (LTP) and cognitive performance in rats and mice. Neuropharmacology. 92. 170–182. 22 indexed citations

O‘Hare, Eugene, Ross Jeggo, Eun‐Mee Kim, et al.. (2015). Lack of support for bexarotene as a treatment for Alzheimer's disease. Neuropharmacology. 100. 124–130. 30 indexed citations

Hebeisen, Simon, Nuno Pires, Ana I. Loureiro, et al.. (2014). Eslicarbazepine and the enhancement of slow inactivation of voltage-gated sodium channels: A comparison with carbamazepine, oxcarbazepine and lacosamide. Neuropharmacology. 89. 122–135. 107 indexed citations

Bursi, Roberta, Gül Erdemli, Robert A. Campbell, et al.. (2011). Translational PK–PD modelling of molecular target modulation for the AMPA receptor positive allosteric modulator Org 26576. Psychopharmacology. 218(4). 713–724. 13 indexed citations

10.

O‘Hare, Eugene, et al.. (2010). RS-0406 Arrests Amyloid-β Oligomer-Induced Behavioural Deterioration In Vivo. Behavioural Brain Research. 210(1). 32–37. 16 indexed citations

11.

O‘Hare, Eugene, et al.. (2009). Behavioural deterioration induced by intrahippocampal NAC61–95 injections and attenuation with ibuprofen. Behavioural Brain Research. 208(1). 274–277. 5 indexed citations

12.

Berg, Hugo A. van den, et al.. (2008). The Development of Insulin Resistance in Type 2 Diabetes: Insights from Knockout Studies. Science Progress. 91(3). 285–316. 5 indexed citations

13.

Lee, Kevin & David Spanswick. (2006). Pain. Seminars in Cell and Developmental Biology. 17(5). 541–543. 1 indexed citations

14.

Top, M. van den & David Spanswick. (2006). Integration of metabolic stimuli in the hypothalamic arcuate nucleus. Progress in brain research. 153. 141–154. 34 indexed citations

15.

Bramlage, Peter, et al.. (2006). Cardiovascular Risk Management by Blocking the Endocannabinoid System. Experimental and Clinical Endocrinology & Diabetes. 114(2). 75–81. 9 indexed citations

16.

Top, M. van den, D. Lyons, Kevin Lee, et al.. (2006). Pharmacological and molecular characterization of ATP-sensitive K+ conductances in CART and NPY/AgRP expressing neurons of the hypothalamic arcuate nucleus. Neuroscience. 144(3). 815–824. 37 indexed citations

17.

Spanswick, David, et al.. (2004). Nitric oxide inhibits NMDA currents in a subpopulation of substantia gelatinosa neurons of the adult rat spinal cord. Neuroscience Letters. 359(3). 180–184. 6 indexed citations

18.

Spanswick, David & Kevin Lee. (2003). Emerging antiobesity drugs. Expert Opinion on Emerging Drugs. 8(1). 217–237. 5 indexed citations

19.

Top, M. van den, Ruud M. Buijs, Jan M. Ruijter, et al.. (2001). Melatonin generates an outward potassium current in rat suprachiasmatic nucleus neurones in vitro independent of their circadian rhythm. Neuroscience. 107(1). 99–108. 72 indexed citations

20.

Harvey, Jenni, Fiona-Mairéad McKenna, Paco S. Herson, David Spanswick, & Michael L.J. Ashford. (1997). Leptin activates ATP‐sensitive potassium channels in the rat insulin‐secreting cell line, CRI‐G1. The Journal of Physiology. 504(3). 527–535. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact